An insurance policy does more than just pay it claims, it pays to defend you against lawsuits. As the Marriott breach shows, lawsuits can come quickly and they are not cheap to defend against.
Today there was an article in STAT about the shortage of manufacturing capacity for gene therapy companies (find the article here). The article goes on to talk about how the problem might only get worse as companies pursue indications in larger patient populations and the trial sizes get bigger and bigger. There was also a … Continue reading How CFOs are Protecting Themselves From Manufacturing Disruptions as Gene Therapy and Immunotherapy Manufacting is Being Stretched Thin
Today I had the privilege of attending the NJ Tech Council CFO Forum at EY in Iselin (Metropark), NJ. The featured speaker was Jim Mastakas (bio), the current Senior VP and CFO of Virtus Pharmaceuticals, and who previously worked at Amneal. Jim was there to speak about his time at Amneal and the deal he … Continue reading NJ Tech Council CFO Forum – An Overview of the Amneal/Impax Merger